Categories Earnings, Retail

Designer Brands (NYSE: DBI): Q3 2019 Earnings Snapshot

— Designer Brands, Inc. (NYSE: DBI) reported adjusted earnings of $0.67 per share for the third quarter of 2019, vs. $0.74 per share expected.

— Net income rose to $43.46 million or $0.60 per share from $39.32 million or $0.48 per share in the third quarter of last year

— Total revenues moved up 12% annually to $936.26 million, vs. $935.03 million expected

— Comparable sales increased 0.3%, delivering a two-year comparable sales growth of 7.6%

— Repurchased 1 million shares in the third quarter and 7.1 million shares year-to-date; declared a quarterly dividend of $0.25 per share

— Cut full-year adjusted EPS outlook to $1.50-$1.55 from the previous range of $1.87 to $1.97

— Expects full-year revenue to grow in low double-digit, which is in line with the earlier forecast

— Expects comparable sales growth to be flat in fiscal 2019, down from the earlier forecast

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips

Most Popular

CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%

Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss

Key metrics from Nike’s (NKE) Q2 2025 earnings results

NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net

FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips

Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,

Comments

  1. Pingback: future university
  2. Pingback: Economics
  3. Pingback: fue
  4. Pingback: led luci camera
  5. Pingback: Fiverr Earn
  6. Pingback: Fiverr Earn
  7. Pingback: fiverrearn.com
  8. Pingback: fiverrearn.com
  9. Pingback: weather
  10. Pingback: fiverrearn.com
  11. Pingback: french bulldog
  12. Pingback: fiverrearn.com
  13. Pingback: exotic bullies
  14. Pingback: jute rugs
  15. Pingback: seo in Greece
  16. Pingback: bewerto
  17. Pingback: Pandora earrings
  18. Pingback: slot online
  19. Pingback: Fiverr
  20. Pingback: grey bulldog
  21. Pingback: future university
  22. Pingback: french bulldog
  23. Pingback: six sigma
  24. Pingback: FUE
  25. Pingback: FUE
  26. Pingback: Packing materials
  27. Pingback: Classic Books 500
  28. Pingback: FiverrEarn
  29. Pingback: Fiverr.Com
  30. Pingback: Coach
  31. Pingback: FiverrEarn
  32. Pingback: FiverrEarn
  33. Pingback: FiverrEarn
  34. Pingback: partners
  35. Pingback: puravive
  36. Pingback: ultra k9 pro
  37. Pingback: FiverrEarn
  38. Pingback: FiverrEarn
  39. Pingback: FiverrEarn
  40. Pingback: live sex cams
  41. Pingback: FiverrEarn
  42. Pingback: FiverrEarn
  43. Pingback: FiverrEarn
  44. Pingback: french bulldog
  45. Pingback: FiverrEarn
  46. Pingback: FiverrEarn
  47. Pingback: FiverrEarn
  48. Pingback: FiverrEarn
  49. Pingback: digital marketing
  50. Pingback: Kuliah Termurah
  51. Pingback: FiverrEarn
  52. Pingback: FiverrEarn
  53. Pingback: FiverrEarn
  54. Pingback: cheap sex cams
  55. Pingback: fullersears.com
  56. Pingback: canine probiotics
  57. Pingback: live sex cams
  58. Pingback: live sex cams
  59. Pingback: live sex cams
  60. Pingback: rare breed-trigger
  61. Pingback: Website Designing
  62. Pingback: 늑대닷컴
  63. Pingback: Slot online mobile
  64. Pingback: nang delivery
  65. Pingback: superslot
  66. Pingback: allgame
  67. Pingback: 918kiss
  68. Pingback: หวย24
  69. Pingback: Skincare serum
  70. Pingback: pg slot
  71. Pingback: cybersécurité
  72. Pingback: Life Coach Chelsea
  73. Pingback: upstate hotels
  74. Pingback: MasumINTL
  75. Pingback: FB URL Shortener
  76. Pingback: masumintl
  77. Pingback: ItMe.Xyz
  78. Pingback: itme.xyz

Comments are closed.

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top